跳至主要内容
临床试验/PER-086-20
PER-086-20尚未招募未知

CLINICAL STUDY, DOUBLE-BLIND AND RANDOMIZED, TO EVALUATE THE EFFECTIVENESS AND SAFETY OF SALBUTAMOL 2MG + AMBROXOL 7.5MG / 5ML (SALBUVENT EXPECTORANT SYRUP) COMPARED WITH SALBUTAMOL 2MG / 5ML IN PATIENTS OF ACUTE BRONCHITIS WITH BRONCHOSPASM

aboratorios Elifarma S.A.,0 个研究点目标入组 23 人开始时间: 2021年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants between 2 to 17 years of age receiving a prescription for treatment of SOBA and / or Acute Bronchitis with bronchospasm.
  • Be able to understand, sign and date an informed consent / informed consent / parental consent document (where applicable) according to the guidelines of good clinical practice and local regulations.
  • Commitment to comply with the assigned treatment and tests.
  • Desire to adhere to the treatment and follow-up program.

排除标准

  • Children under 2 years old
  • Treatment with drugs of similar therapeutic action
  • Cardiovascular diseases such as angina pectoris, arrhythmias, heart failure, coronary heart failure, degenerative heart diseases
  • Hypersensitivity to Salbutamol
  • Hypersensitivity to Ambroxol
  • Hypersensitivity to any of the excipients of the products
  • Pregnant and / or lactating patients.
  • Arterial hypertension
  • Cerebrovascular disease
  • Mellitus diabetes
  • Hyperthyroidism
  • Ketoacidosis; pheochromocytoma
  • Active gastric ulcer
  • Parkinson´s disease.

研究者

发起方
aboratorios Elifarma S.A.,

相似试验

进行中(未招募)
3 期
CLINICAL STUDY, DOUBLE-BLIND, RANDOMIZED TO EVALUATE THE EFFICACY AND SAFETY OF SODIUM PICOSULPHATE 2.5MG /100ML (CALORIE-FREE MARKOS PURGANT LEMONADE), PLACEBO CONTROLLED IN PATIENTS WITH FUNCTIONAL CHRONIC CONSTIPATIOK599 Functional intestinal disorder, unspecifiedFunctional intestinal disorder, unspecifiedK599
PER-006-21ABORATORIOS FARMACEUTICOS MARKOS S.A276
进行中(未招募)
3 期
CLINICAL STUDY, DOUBLE-BLIND, RANDOMIZED TO EVALUATE THE EFFICACY AND SAFETY OF SODIUM PICOSULPHATE 2.5MG /100ML (MARKOS PURGANT LEMONADE), PLACEBO CONTROLLED IN PATIENTS WITH FUNCTIONAL CHRONIC CONSTIPATIOK599 Functional intestinal disorder, unspecifiedFunctional intestinal disorder, unspecifiedK599
PER-005-21ABORATORIOS FARMACEUTICOS MARKOS S.A165
尚未招募
3 期
CLINICAL TRIAL, DOUBLE-BLIND AND RANDOMIZED, TO EVALUATE THE EFFICACY AND SAFETY OF THE FERANIN®? FOL 1000 COMPLEX (FERRIC HYDROXIDE POLYMALTOSATE 100MG + FOLIC ACID 1000UG AT A COMBINED FIXED DOSE) COMPARED WITH FERROUS SULFATE (120MG OF ELEMENTAL IRON) + FOLIC ACID 800UG ADMINISTERED SEPARATELY, ON ANEMIA DURING PREGNANCY.O990 Anaemia complicating pregnancy, childbirth and the puerperiumAnaemia complicating pregnancy, childbirth and the puerperiumO990
PER-028-22QUIMICA SUIZA SOCIEDAD ANONIMA CERRADA - QUIMICA SUIZA S.A.C.
招募中
3 期
A Clinical Study to Assess the Efficacy and Safety of Amrith Noni Artho Plus in Patients with Gout flare.
CTRI/2023/10/058982Valyou Products Private Limited
招募中
2 期
Effect Of Nasal Drop Administration In Tension Type Headache
CTRI/2024/05/067250ational Institute of Ayurveda